1980s: C. Ronald Kahn and his team define the molecular mechanism of insulin action and how it is altered in insulin resistant states such as type 2 diabetes and obesity.
•
2009: Researchers in the lab of C. Ronald Kahn, MD discover that brown fat is present in some adults, providing a new target for the treatment of obesity.
•
1996: A molecular pathway (called NF-κB) is identified in fat and the liver that is activated by obesity (and a fatty diet) and causes the insulin resistance that can lead to type 2 diabetes (Steven E. Shoelson, M.D., Ph.D.).
In 2007, Wily Mo Peña and his MoPeace Foundation teamed up with Joslin Diabetes Center's Latino Diabetes Initiative for the Beisbol y Salud Latino Diabetes and Health Festival to educate Latino men, women and children about type 2 diabetes.
World Trade Center | center | Kennedy Space Center | Walker Art Center | Woodrow Wilson International Center for Scholars | Marshall Space Flight Center | Rockefeller Center | Lyndon B. Johnson Space Center | Goddard Space Flight Center | Georgia World Congress Center | Staples Center | Lincoln Center for the Performing Arts | Tanglewood Music Center | National Center for Biotechnology Information | John F. Kennedy Center for the Performing Arts | Diabetes mellitus type 1 | Center for Constitutional Rights | Georgetown University Law Center | Art Center College of Design | Southern Poverty Law Center | Diabetes mellitus | George C. Marshall European Center for Security Studies | Beth Israel Deaconess Medical Center | University of Pittsburgh Medical Center | Prudential Center | Painted Bride Art Center | National Center for Atmospheric Research | Langley Research Center | German Aerospace Center | center (basketball) |
Dr. Thomas Aoki, former Head of Metabolism Research at the Joslin Diabetes Center in Boston, Massachusetts, and a current Professor of Medicine at the University of California, Davis, was the pioneer of using pulsatile insulin in the treatment of diabetes.